Skip to main content

Table 2 Multiple logistic regression models for associations between clinical and biochemical variables and the progression of diabetic nephropathy in a total of 154 subjects with T1D

From: Glycated albumin and the risk of micro- and macrovascular complications in subjects with Type 1 Diabetes

  Model 1 Model 2 Model 3
  (R 2= 0.28) (R 2= 0.20) (R 2= 0.28)
Variables OR 95 % CI P OR 95 % CI P OR 95 % CI P
Age, per year 1.03 0.99–1.07 0.132 1.03 0.99–1.06 0.188 1.03 0.99–1.07 0.136
Obesity (0 = no, 1 = yes) 1.92 0.64–5.78 0.243 1.95 0.69–5.55 0.210 1.94 0.64–5.81 0.242
Duration of diabetes, per 5years 1.44 1.01–2.07 0.047 1.28 0.92–1.77 0.145 1.44 1.01–2.07 0.047
Hypertension (0 = no, 1 = yes) 2.32 0.77–6.99 0.134 2.09 0.79–5.83 0.160 2.32 0.77–6.98 0.136
Albuminuria at baseline (0 = no, 1 = yes) 2.63 1.03–6.73 0.043 2.86 1.16–7.07 0.023 2.64 1.03–6.74 0.043
Statin use (0 = no, 1 = yes) 1.89 0.74–4.88 0.186 1.49 0.59–3.75 0.403 1.91 0.73–5.01 0.188
CKD stage at baseline          
 Stage1 Reference Reference Reference
 Stage2 0.55 0.16–1.86 0.338 0.71 0.23–2.24 0.559 0.55 0.16–1.86 0.337
 Stage3 and 4 0.09 0.01–1.30 0.078 0.12 0.01–1.54 0.103 0.09 0.01–1.31 0.078
mean GA (%)* 2.02 1.28–3.17 0.002     2.03 1.27–3.26 0.003
mean HbA1c (%)*     1.21 0.79–1.85 0.390 0.98 0.62–1.54 0.918
  1. CKD chronic kidney disease
  2. *z-standardization of glycemic indices